PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
DIM shows potential in reducing the risk and treating various cancers, including breast, ovarian, gastrointestinal, and non-small-cell lung cancer, by targeting cell survival and proliferation [PMID:40841315, PMID:23140296, PMID:27447608, PMID:40100489].
In mouse models, DIM ameliorated smoking-induced inflammatory amplification, reduced synovial hyperplasia, and inhibited abnormal platelet activation [PMID:40349797, PMID:41076479].
DIM was shown to relieve visceral pain under colitis conditions in mice via the AhR/Nrf2/Arg-1-mediated arginine metabolism pathway [PMID:37216760].
DIM attenuated object recognition memory deficits induced by binge ethanol exposure in mice [PMID:41390010].
DIM demonstrated anti-biofilm activity against Acinetobacter baumannii and Pseudomonas aeruginosa in vitro [PMID:35631553].
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 36972159 (2023) — Indole-3-Carbinol: Occurrence, Health-Beneficial Properties, and Cellular/Molecular Mechanisms. · Annual review of food science and technology
- 2.PMID: 38796426 (2024) — Exosome-sheathed porous silica nanoparticle-mediated co-delivery of 3,3'-diindolylmethane and doxorubicin attenuates cancer stem cell-driven EMT in triple negative breast cancer. · Journal of nanobiotechnology
- 3.PMID: 23140296 (2012) — DIMming ovarian cancer growth. · Current drug targets
- 4.PMID: 40841315 (2025) — Cruciferous Vegetables, Bioactive Metabolites, and Microbiome for Breast Cancer Prevention. · Annual review of nutrition
- 5.PMID: 37216760 (2023) — 3, 3'-diindolylmethane enhances macrophage efferocytosis and subsequently relieves visceral pain via the AhR/Nrf2/Arg-1-mediated arginine metabolism pathway.